Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Kiora Pharmaceuticals Appoints Keith Lane As Executive Vice President for Clinical Development
PUBLIC · KPRXSep 08, 2026•about 2 hours ago
Position
Executive Vice President
Company
KIORA PHARMACEUTICALS
Keith Lane
EncinitasHealthcare
Description
On September 8, 2026, Kiora Pharmaceuticals appointed Keith Lane as Executive Vice President, Head of Clinical Development and Regulatory Affairs. Lane's previous experience includes serving as Chief Scientific Officer at Ora, Inc., where he oversaw numerous significant ophthalmic trials. His extensive background in clinical operations and regulatory strategy positions him to lead Kiora's development efforts
Company Information
Company
KIORA PHARMACEUTICALS
Location
332 ENCINITAS BOULEVARD
Encinitas, California, United States
About
Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publicly-traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.
Don't miss KIORA PHARMACEUTICALS's next move
Get an email the moment KIORA PHARMACEUTICALS changes its leadership, hires an exec, or expands, usually minutes after it happens.
EncinitasHealthcare